First-line Treatment for Atrial Fibrillation in Cardiology and Geriatric Departments

Atrial Fibrillation Clinical Trial

— ACFA  

Official title:

Assessment of the Usual Choice for a First-line Treatment in Case of Atrial Fibrillation : Comparison Between Cardiology Department and Geriatric Unit.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02884661
• Other study ID #: 2015-05Obs-CHRMT
• Status: Completed
• Phase: N/A
• First received: August 26, 2016
• Last updated: August 26, 2016
• Start date: October 2015
• Est. completion date: December 2015

Study information

• Verified date: August 2016
• Source: Centre Hospitalier Régional Metz-Thionville
• Contact: n/a
• Is FDA regulated: No
• Health authority: France: Commission nationale de l'informatique et des libertés
• Study type: Observational

Clinical Trial Summary

In order to evaluate the implementation for the recommendations about the patient care for atrial fibrillation in aged patients, a non-interventional study is performed retrospectively by comparing two approach of the focus in Cardiology Department and in Geriatric unit.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: December 2015
• Est. primary completion date: December 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 75 Years and older

Eligibility

Inclusion Criteria:

• having an atrial fibrillation

• cared in Cardiology department or in geriatric unit

Exclusion Criteria:

• having a mitral valvulopathy, or a valvular disease with a surgery indication

• having a valvular prosthesis

• history of valve reconstruction

Study Design

Observational Model: Cohort, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Atrial Fibrillation

Locations

Country	Name	City	State
France	CHR Metz-Thionville	Metz Cedex 03

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Régional Metz-Thionville

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Implementation of the recommendations about non-valvular atrial fibrillation		September 1st, 2014 to October 13, 2015	No
Secondary	Socio-demographic data		September 1st, 2014 to October 13, 2015	No
Secondary	Etiologic factors of the atrial fibrillations		September 1st, 2014 to October 13, 2015	No
Secondary	Use of supplementary examinations		September 1st, 2014 to October 13, 2015	No
Secondary	Use of a standard geriatric assessment		September 1st, 2014 to October 13, 2015	No
Secondary	Use of an assessment of the risks of thrombosis and bleeding		September 1st, 2014 to October 13, 2015	No
Secondary	Choice of the anti-thrombosis treatment		September 1st, 2014 to October 13, 2015	No
Secondary	Choice of the anti-arrhythmia treatment		September 1st, 2014 to October 13, 2015	No